C-YYVQMultiomic
multi-omics, AI, precision medicine
discoverydiscovering
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
All companiesC-YYVQ
C-YYVQC-YYVQmulti-omics, AI, precision medicine
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Multiomic multi-omics, AI, precision medicine
Multiomic Health has built a platform for discovering and developing precision medicines for age-related chronic multifactorial diseases. Its initial focus is cardio-renal-metabolic disease, with a first platform use case in chronic kidney disease. The company uses deep longitudinal patient datasets, AI-enabled data science, experimental biology, multiple omics modalities, and longitudinal clinical phenotyping to identify patient subpopulations and develop therapeutics with companion diagnostics.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Multiomic — Far from goals · Bottom quartile. Derived deterministically from 3 extracted project(s). Most-advanced status: undisclosed. Band: far. Modifiers: +5 depth (2 programs at undisclosed).…
Source: Deterministic